Published in Bone on August 16, 2008
Dentin sialoprotein and dentin phosphoprotein have distinct roles in dentin mineralization. Matrix Biol (2009) 1.64
Dentin sialophosphoprotein in biomineralization. Connect Tissue Res (2010) 1.29
Loss of dentin sialophosphoprotein leads to periodontal diseases in mice. J Periodontal Res (2012) 1.05
Glycosaminoglycan chain of dentin sialoprotein proteoglycan. J Dent Res (2010) 1.04
The rescue of dentin matrix protein 1 (DMP1)-deficient tooth defects by the transgenic expression of dentin sialophosphoprotein (DSPP) indicates that DSPP is a downstream effector molecule of DMP1 in dentinogenesis. J Biol Chem (2013) 1.02
Fourier transform infrared imaging of femoral neck bone: reduced heterogeneity of mineral-to-matrix and carbonate-to-phosphate and more variable crystallinity in treatment-naive fracture cases compared with fracture-free controls. J Bone Miner Res (2013) 0.99
Expression of dentin sialophosphoprotein in non-mineralized tissues. J Histochem Cytochem (2011) 0.98
Fourier transform infrared spectroscopic imaging parameters describing acid phosphate substitution in biologic hydroxyapatite. Calcif Tissue Int (2013) 0.96
Dentin sialophosphoprotein and dentin matrix protein-1: Two highly phosphorylated proteins in mineralized tissues. Arch Oral Biol (2012) 0.96
Distribution of small integrin-binding ligand, N-linked glycoproteins (SIBLING) in the articular cartilage of the rat femoral head. J Histochem Cytochem (2010) 0.93
Expression and distribution of SIBLING proteins in the predentin/dentin and mandible of hyp mice. Oral Dis (2010) 0.90
Partial blocking of mouse DSPP processing by substitution of Gly(451)-Asp(452) bond suggests the presence of secondary cleavage site(s). Connect Tissue Res (2011) 0.89
Characterization of dystrophic calcification induced in mice by cardiotoxin. Calcif Tissue Int (2009) 0.86
Domain of dentine sialoprotein mediates proliferation and differentiation of human periodontal ligament stem cells. PLoS One (2013) 0.85
Tissue-specific expression of dentin sialophosphoprotein (DSPP) and its polymorphisms in mouse tissues. Cell Biol Int (2009) 0.83
Adaptive calcified matrix response of dental pulp to bacterial invasion is associated with establishment of a network of glial fibrillary acidic protein+/glutamine synthetase+ cells. Am J Pathol (2010) 0.82
Dentin sialophosphoprotein (DSPP) plays an essential role in the postnatal development and maintenance of mouse mandibular condylar cartilage. J Histochem Cytochem (2013) 0.79
Effect of HIP/ribosomal protein L29 deficiency on mineral properties of murine bones and teeth. Bone (2010) 0.79
Transgenic expression of Dspp partially rescued the long bone defects of Dmp1-null mice. Matrix Biol (2015) 0.78
Accelerated enamel mineralization in Dspp mutant mice. Matrix Biol (2016) 0.77
Hierarchical analysis and multi-scale modelling of rat cortical and trabecular bone. J R Soc Interface (2015) 0.77
Adhesive and migratory effects of phosphophoryn are modulated by flanking peptides of the integrin binding motif. PLoS One (2014) 0.77
Intrinsically disordered proteins and biomineralization. Matrix Biol (2016) 0.76
Brief mechanical ventilation impacts airway cartilage properties in neonatal lambs. Pediatr Pulmonol (2011) 0.76
Transgenic expression of dentin phosphoprotein inhibits skeletal development. Eur J Histochem (2016) 0.76
Fourier Transform Infrared Spectroscopic Imaging of Fracture Healing in the Normal Mouse. J Spectrosc (Hindawi) (2015) 0.75
Recombinant Amelogenin Protein Induces Apical Closure and Pulp Regeneration in Open-apex, Nonvital Permanent Canine Teeth. J Endod (2015) 0.75
Dentin sialophosphoprotein knockout mouse teeth display widened predentin zone and develop defective dentin mineralization similar to human dentinogenesis imperfecta type III. J Biol Chem (2003) 3.03
Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect Tissue Res (2003) 3.03
Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis. Crit Rev Oral Biol Med (2004) 3.01
Dentin phosphoprotein and dentin sialoprotein are cleavage products expressed from a single transcript coded by a gene on human chromosome 4. Dentin phosphoprotein DNA sequence determination. J Biol Chem (1997) 2.69
Nucleation of hydroxyapatite by bone sialoprotein. Proc Natl Acad Sci U S A (1993) 2.50
DMP1 depletion decreases bone mineralization in vivo: an FTIR imaging analysis. J Bone Miner Res (2005) 2.46
Gene expression patterns of murine dentin matrix protein 1 (Dmp1) and dentin sialophosphoprotein (DSPP) suggest distinct developmental functions in vivo. J Bone Miner Res (1997) 2.46
DSPP mutation in dentinogenesis imperfecta Shields type II. Nat Genet (2001) 2.39
FT-IR imaging of native and tissue-engineered bone and cartilage. Biomaterials (2006) 2.27
In vitro effects of dentin matrix protein-1 on hydroxyapatite formation provide insights into in vivo functions. J Biol Chem (2004) 2.25
Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner (1993) 2.16
Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem (2002) 2.12
Bone development and age-related bone loss in male C57BL/6J mice. Bone (2003) 2.02
Expression of SIBLINGs and their partner MMPs in salivary glands. J Dent Res (2004) 1.99
Loading induces site-specific increases in mineral content assessed by microcomputed tomography of the mouse tibia. Bone (2005) 1.95
Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone. Calcif Tissue Int (2002) 1.91
Renal expression of SIBLING proteins and their partner matrix metalloproteinases (MMPs). Kidney Int (2005) 1.85
The expression of dentin sialophosphoprotein gene in bone. J Dent Res (2002) 1.84
Dentin matrix protein 1 immobilized on type I collagen fibrils facilitates apatite deposition in vitro. J Biol Chem (2003) 1.83
Importance of phosphorylation for osteopontin regulation of biomineralization. Calcif Tissue Int (2005) 1.75
Genomic organization, chromosomal mapping, and promoter analysis of the mouse dentin sialophosphoprotein (Dspp) gene, which codes for both dentin sialoprotein and dentin phosphoprotein. J Biol Chem (1998) 1.73
Concentration-dependent effects of dentin phosphophoryn in the regulation of in vitro hydroxyapatite formation and growth. Bone Miner (1990) 1.70
Mutation of the signal peptide region of the bicistronic gene DSPP affects translocation to the endoplasmic reticulum and results in defective dentine biomineralization. Hum Mol Genet (2002) 1.64
Phosphorylation of phosphophoryn is crucial for its function as a mediator of biomineralization. J Biol Chem (2005) 1.49
Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers. Clin Cancer Res (2004) 1.43
Infrared analysis of the mineral and matrix in bones of osteonectin-null mice and their wildtype controls. J Bone Miner Res (2003) 1.39
Dentin glycoprotein: the protein in the middle of the dentin sialophosphoprotein chimera. J Biol Chem (2005) 1.38
Comparison of mineral quality and quantity in iliac crest biopsies from high- and low-turnover osteoporosis: an FT-IR microspectroscopic investigation. Osteoporos Int (2005) 1.33
Dentin sialoprotein (DSP) has limited effects on in vitro apatite formation and growth. Calcif Tissue Int (2000) 1.26
Extracellular matrix proteins and the dynamics of dentin formation. Connect Tissue Res (2002) 1.26
Molecular basis of human dentin diseases. Am J Med Genet A (2006) 1.24
A method for examining the chemical basis for bone disease: synchrotron infrared microspectroscopy. Cell Mol Biol (Noisy-le-grand) (1998) 1.03
Induction of collagen mineralization by a bone sialoprotein--decorin chimeric protein. J Biomed Mater Res (2001) 0.97
Adsorption and interactions of dentine phosphoprotein with hydroxyapatite and collagen. Eur J Oral Sci (2006) 0.91
Association of specific proteolytic processing of bone sialoprotein and bone acidic glycoprotein-75 with mineralization within biomineralization foci. J Biol Chem (2007) 0.91
Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressiveness. Int J Cancer (2006) 0.89
Role of phosphophoryn in dentin mineralization. Cells Tissues Organs (2005) 0.89
Dental structural diseases mapping to human chromosome 4q21. Connect Tissue Res (2003) 0.88
Characterization of very young mineral phases of bone by solid state 31phosphorus magic angle sample spinning nuclear magnetic resonance and X-ray diffraction. Calcif Tissue Int (1992) 0.88
Binding of dentin noncollagenous matrix proteins to biological mineral crystals: an atomic force microscopy study. Calcif Tissue Int (2002) 0.84
Synthesis of a potentially bioactive, hydroxyapatite-nucleating molecule. Calcif Tissue Int (2006) 0.81
Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2010) 6.00
Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2013) 5.76
A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol (2008) 4.28
Deletion of dentin matrix protein-1 leads to a partial failure of maturation of predentin into dentin, hypomineralization, and expanded cavities of pulp and root canal during postnatal tooth development. J Biol Chem (2004) 3.21
Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science (2003) 3.05
Dentin sialophosphoprotein knockout mouse teeth display widened predentin zone and develop defective dentin mineralization similar to human dentinogenesis imperfecta type III. J Biol Chem (2003) 3.03
Ameloblastin is a cell adhesion molecule required for maintaining the differentiation state of ameloblasts. J Cell Biol (2004) 3.00
DMP1 depletion decreases bone mineralization in vivo: an FTIR imaging analysis. J Bone Miner Res (2005) 2.46
Dentin matrix protein 1, a target molecule for Cbfa1 in bone, is a unique bone marker gene. J Bone Miner Res (2002) 2.36
In vitro effects of dentin matrix protein-1 on hydroxyapatite formation provide insights into in vivo functions. J Biol Chem (2004) 2.25
The KIF3 motor transports N-cadherin and organizes the developing neuroepithelium. Nat Cell Biol (2005) 2.13
Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures. J Bone Miner Res (2012) 2.05
Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood (2010) 1.98
Control of the development of CD8αα+ intestinal intraepithelial lymphocytes by TGF-β. Nat Immunol (2011) 1.94
PI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer. Clin Cancer Res (2013) 1.81
COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. Hum Mutat (2011) 1.77
Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell (2009) 1.72
Cdk5 phosphorylation of doublecortin ser297 regulates its effect on neuronal migration. Neuron (2004) 1.70
Bone fragility and collagen cross-links. J Bone Miner Res (2004) 1.68
Mechanical loading stimulates dentin matrix protein 1 (DMP1) expression in osteocytes in vivo. J Bone Miner Res (2003) 1.66
Dentin sialoprotein and dentin phosphoprotein have distinct roles in dentin mineralization. Matrix Biol (2009) 1.64
Infrared assessment of bone quality: a review. Clin Orthop Relat Res (2011) 1.63
Cyclin-dependent kinase 5 regulates E2F transcription factor through phosphorylation of Rb protein in neurons. Cell Cycle (2012) 1.62
Does sex matter in musculoskeletal health? The influence of sex and gender on musculoskeletal health. J Bone Joint Surg Am (2005) 1.61
Variations in nanomechanical properties and tissue composition within trabeculae from an ovine model of osteoporosis and treatment. Bone (2012) 1.60
ERG oncogene modulates prostaglandin signaling in prostate cancer cells. Cancer Biol Ther (2011) 1.56
Use of FTIR spectroscopic imaging to identify parameters associated with fragility fracture. J Bone Miner Res (2009) 1.54
Spatial variation in osteonal bone properties relative to tissue and animal age. J Bone Miner Res (2009) 1.52
Mesenchymal stem cells and insulin-like growth factor-I gene-enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons. J Orthop Res (2009) 1.48
Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity. Bone (2009) 1.47
Effects of surface roughness and maximum load on the mechanical properties of cancellous bone measured by nanoindentation. J Biomed Mater Res A (2006) 1.46
Nanoscale X-ray microscopic imaging of mammalian mineralized tissue. Microsc Microanal (2010) 1.45
Effects of tissue age on bone tissue material composition and nanomechanical properties in the rat cortex. J Biomed Mater Res A (2010) 1.45
Cdk5 is required for multipolar-to-bipolar transition during radial neuronal migration and proper dendrite development of pyramidal neurons in the cerebral cortex. Development (2007) 1.40
Cyclin-dependent kinase-5 is involved in neuregulin-dependent activation of phosphatidylinositol 3-kinase and Akt activity mediating neuronal survival. J Biol Chem (2003) 1.38
DLX3 mutation associated with autosomal dominant amelogenesis imperfecta with taurodontism. Am J Med Genet A (2005) 1.36
Multiplexed target detection using DNA-binding dye chemistry in droplet digital PCR. Anal Chem (2013) 1.35
Delineation of TMPRSS2-ERG splice variants in prostate cancer. Clin Cancer Res (2008) 1.35
Cyclin-dependent kinase 5 activity regulates pain signaling. Proc Natl Acad Sci U S A (2006) 1.34
Dilatational band formation in bone. Proc Natl Acad Sci U S A (2012) 1.32
Infrared spectroscopic characterization of mineralized tissues. Vib Spectrosc (2005) 1.31
Mineral changes in osteoporosis: a review. Clin Orthop Relat Res (2006) 1.31
Cyclin-dependent kinase 5 modulates nociceptive signaling through direct phosphorylation of transient receptor potential vanilloid 1. Proc Natl Acad Sci U S A (2006) 1.31
Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway. J Biol Chem (2001) 1.30
Finite element models predict cancellous apparent modulus when tissue modulus is scaled from specimen CT-attenuation. J Biomech (2004) 1.30
Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model. Clin Cancer Res (2012) 1.30
Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35. J Biol Chem (2008) 1.30
Contribution of mineral to bone structural behavior and tissue mechanical properties. Calcif Tissue Int (2010) 1.30
Fgfr4 is required for effective muscle regeneration in vivo. Delineation of a MyoD-Tead2-Fgfr4 transcriptional pathway. J Biol Chem (2005) 1.27
Cancellous bone adaptation to tibial compression is not sex dependent in growing mice. J Appl Physiol (1985) (2010) 1.27
Singleton-Merten syndrome: an autosomal dominant disorder with variable expression. Am J Med Genet A (2013) 1.26
Bone mass is preserved and cancellous architecture altered due to cyclic loading of the mouse tibia after orchidectomy. J Bone Miner Res (2008) 1.25
A novel regulatory role for stromal-derived factor-1 signaling in bone morphogenic protein-2 osteogenic differentiation of mesenchymal C2C12 cells. J Biol Chem (2007) 1.25
In vivo cyclic axial compression affects bone healing in the mouse tibia. J Orthop Res (2006) 1.24
In vivo cyclic compression causes cartilage degeneration and subchondral bone changes in mouse tibiae. Arthritis Rheum (2013) 1.24
Dentin sialoprotein and dentin phosphoprotein overexpression during amelogenesis. J Biol Chem (2005) 1.24
Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway. Cancer Res (2009) 1.24
Composition of calcifications in children with juvenile dermatomyositis: association with chronic cutaneous inflammation. Arthritis Rheum (2006) 1.23
Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling. Proc Natl Acad Sci U S A (2005) 1.21
Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability. J Neurochem (2005) 1.20
MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma. Cancer Lett (2013) 1.19
Partial rescue of the amelogenin null dental enamel phenotype. J Biol Chem (2008) 1.19
In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. J Bone Miner Res (2002) 1.17
Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cells. Int J Biochem Cell Biol (2010) 1.17
Bone morphogenetic protein 2 mediates dentin sialophosphoprotein expression and odontoblast differentiation via NF-Y signaling. J Biol Chem (2008) 1.16
Dph3, a small protein required for diphthamide biosynthesis, is essential in mouse development. Mol Cell Biol (2006) 1.16
Tibial compression is anabolic in the adult mouse skeleton despite reduced responsiveness with aging. Bone (2011) 1.16
Spatial expression of Cbfa1/Runx2 isoforms in teeth and characterization of binding sites in the DSPP gene. Connect Tissue Res (2002) 1.15
Dentin phosphoprotein compound mutation in dentin sialophosphoprotein causes dentinogenesis imperfecta type III. Am J Med Genet A (2005) 1.15
Transgenic mouse expressing human mutant alpha-galactosidase A in an endogenous enzyme deficient background: a biochemical animal model for studying active-site specific chaperone therapy for Fabry disease. Biochim Biophys Acta (2004) 1.14
Genetically altered mouse models: the good, the bad, and the ugly. Crit Rev Oral Biol Med (2003) 1.14
Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J (2002) 1.13
Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse. Bone (2005) 1.13
Cdk5: a new player in pain signaling. Cell Cycle (2006) 1.10
Bone quality: from bench to bedside: opening editorial comment. Clin Orthop Relat Res (2011) 1.09
Critical roles of the TGF-beta type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development. Dev Biol (2009) 1.09
Brief bone morphogenetic protein 2 treatment of glucocorticoid-inhibited MC3T3-E1 osteoblasts rescues commitment-associated cell cycle and mineralization without alteration of Runx2. J Biol Chem (2003) 1.08
Conditional overexpression of TGF-beta1 disrupts mouse salivary gland development and function. Lab Invest (2010) 1.08
Cyclin-dependent kinase 5 is a regulator of podocyte differentiation, proliferation, and morphology. Am J Pathol (2004) 1.08
Functional characterization of barley betaglucanless mutants demonstrates a unique role for CslF6 in (1,3;1,4)-β-D-glucan biosynthesis. J Exp Bot (2011) 1.08
Comparison of body weight and gene expression in amelogenin null and wild-type mice. Eur J Oral Sci (2006) 1.08
Fourier transform infrared imaging microspectroscopy and tissue-level mechanical testing reveal intraspecies variation in mouse bone mineral and matrix composition. Calcif Tissue Int (2008) 1.08
Tau phosphorylation by cyclin-dependent kinase 5/p39 during brain development reduces its affinity for microtubules. J Biol Chem (2003) 1.07
In vivo tibial stiffness is maintained by whole bone morphology and cross-sectional geometry in growing female mice. J Biomech (2010) 1.06